Incyte CEO Hervé Hoppenot talkes about plans to turn the company’s Augustine Cut-off offices into an R&D center while remodeling old MBNA buildings for everyone else. Some of Incyte’s biopharmaceutical drugs can help skin problems and one seems to be a cure for vitiligo, CEO Hervé Hoppenot said in an update Thursday. He also said…
